Departments of 1 Internal Medicine and 2 Medical Physiology, Scott & White Hospital and Texas A&M University System Health Science Center, College of Medicine, and 3 Central Texas Veterans Health Care System, Temple, TX 76504
![]() |
ABSTRACT |
---|
The objective of this review article is to discuss the role of secretin and its receptor in the regulation of the secretory activity of intrahepatic bile duct epithelial cells (i.e., cholangiocytes). After a brief overview of cholangiocyte functions, we provide an historical background for the role of secretin and its receptor in the regulation of ductal secretion. We review the newly developed experimental in vivo and in vitro tools, which lead to understanding of the mechanisms of secretin regulation of cholangiocyte functions. After a description of the intracellular mechanisms by which secretin stimulates ductal secretion, we discuss the heterogeneous responses of different-sized intrahepatic bile ducts to gastrointestinal hormones. Furthermore, we outline the role of a number of cooperative factors (e.g., nerves, alkaline phosphatase, gastrointestinal hormones, neuropeptides, and bile acids) in the regulation of secretin-stimulated ductal secretion. Finally, we discuss other factors that may also play an important role in the regulation of secretin-stimulated ductal secretion.
bile flow; adenosine 3',5'-cyclic monophosphate; cystic fibrosis transmembrane regulator; chloride/bicarbonate exchanger; gastrointestinal hormones; intrahepatic biliary epithelium; peptides; nerves
![]() |
INTRODUCTION |
---|
IN THE LIVER TWO TYPES of epithelia
(i.e., hepatocytes and cholangiocytes) contribute to bile secretion
(12, 27, 34, 73, 105, 132, 135, 136, 140).
Separate hepatic (105) and ductular transport mechanisms
(6, 8, 10, 12, 13, 16, 18, 20, 27, 34, 43-46, 63, 75)
allow for regulation of bile volume and composition required for
changing physiological needs. The bile acid-dependent flow derived from
hepatocyte canalicular secretion accounts for 30-60% of
spontaneous basal bile flow (105). A canalicular bile
acid-independent secretion, probably caused by transport into bile of
organic solutes (glutathione) and inorganic electrolytes, accounts for
30-60% of basal bile flow (105). At the level of the
bile ducts, both secretion and reabsorption of fluid and inorganic
electrolytes modify canalicular bile (6, 10-13, 16, 22, 27,
34, 43-46, 63, 75, 93-95, 119, 120, 135, 143). Ductal
secretion chiefly occurs in response to secretin and represents 30% of
basal bile flow in humans and 10% in rats (11, 140).
Glutathione is present in bile but is almost quantitatively broken down
within the biliary tree by hepatic -glutamyltransferase (1,
90, 112). Cholangiocytes possess specific membrane transport systems for a large number of substrates. For example, cholangiocytes absorb glucose (81), bile acids (8, 51, 80),
and amino acids (50, 125) from bile. Human cholangiocytes
are also involved in the transport of secretory component and IgA into
bile (137).
The secretory/absorptive properties of the intrahepatic biliary
epithelium are supported by the presence of microvilli on their apical
pole (31, 71, 79). Ductal bile secretion is coordinately
regulated by a number of factors including nerves (16,
83), enzymes [e.g., alkaline phosphatase (AP)
(17)], gastrointestinal hormones [e.g., secretin
(10, 143), somatostatin (143), and gastrin
(63)], peptides [endothelin-1 (ET-1) (38), bombesin, and vasoactive intestinal polypeptide (VIP) (43,
46)], and bile salts (5, 7) (Table
1).
|
Pathologically, cholangiocytes are the target cells in a number of
chronic cholangiopathies including primary biliary cirrhosis (PBC) and
primary sclerosing cholangitis (PSC), diseases that are associated with
cholangiocyte proliferation and/or loss (12, 120). In
rodents, cholangiocyte proliferation/loss is achieved by a number of
pathological maneuvers including bile duct ligation (BDL) (10,
12, 62, 63, 83, 85, 143), experimental cirrhosis [induced by
chronic administration of CCl4 (4) or phenobarbital in conjunction with CCl4 (76)],
experimental fascioliasis [induced by oral administration of 20 metacercariae of Fascioliasis hepatica (88)],
partial hepatectomy (84), acute CCl4
administration (85, 86), vagotomy (83), and
chronic feeding of bile acids (7) or the toxin
-naphthylisothiocyanate (ANIT) (11, 32) (Table
2). These models of bile duct
hyperplasia/ductopenia are closely associated with increases (e.g.,
after BDL, ANIT feeding, oral administration of F. hepatica,
cirrhosis, or partial hepatectomy; Refs. 7,
9-11, 32, 62,
63, 83, 84, 88,
143) or decreases (e.g., after CCl4
administration or vagotomy; Refs. 83, 85,
86) in ductal secretion (Table 2).
|
![]() |
MORPHOLOGY OF INTRAHEPATIC BILIARY EPITHELIUM |
---|
Reviews on cholangiocyte secretory functions are available (12, 19, 27, 34, 73, 120, 132, 135, 136, 140); however, none has specifically focused on the role and mechanisms of action of secretin in the regulation of cholangiocyte secretion. The biliary duct system has been classified into three segments based on duct size (12, 89, 124). This classification includes extrahepatic bile ducts, large bile ducts, and intrahepatic small bile ducts or ductules (12, 89, 124). At the functional level, hepatocyte bile is transferred from the bile canaliculus to the smallest bile ducts (~5 µm in external diameter) through the duct of Hering (12, 89, 124). Small intrahepatic bile ducts (lined by 4-5 cholangiocytes) are characterized by the presence of a basement membrane, tight junctions between cells, and microvilli projecting into the duct lumen (12, 89, 124). Like small branches of a tree, small bile ducts join into intralobular ducts ranging from 20 to 100 µm in cross-sectional diameter (12, 89, 124). In larger bile ducts the lining cholangiocytes are progressively larger and more columnar in shape (12, 89, 124).
![]() |
SECRETIN FUNCTIONS IN THE BODY |
---|
Secretin [a 27-amino acid neuroendocrine peptide synthesized by specific endocrine cells, S cells, localized mainly in the mucosa of the duodenum and proximal jejunum (42, 152, 153)] regulates the physiological functions of many organs including brain [e.g., activation of tyrosine hydroxylase activity (69)], pancreas, intestine, and liver (9-11, 39, 85, 86, 153). Secretin stimulates the gastric secretion of pepsin and inhibits the secretion of gastric acid and food-stimulated gastrin from G cells in the gastric antrum (152, 153). Furthermore, secretin affects the motility of the small intestine, decreases lower esophageal sphincter pressure, relaxes the sphincter of Oddi, and inhibits postprandial emptying (152, 153). Secretin increases heart rate and causes dilatation of peripheral blood vessels (29, 104).
![]() |
HISTORICAL BACKGROUND |
---|
Secretin was originally discovered by Bayliss and Starling, who
demonstrated that this hormone stimulates pancreatic secretion and bile
flow in dogs (28). In vivo studies in dogs with BDL by
Rous and McMaster (122) showed that cholangiocytes secrete water and electrolytes in ductal bile. Andrews (23)
proposed a secretory model in which hepatocytes were responsible for
the hepatic metabolic activity, whereas the intrahepatic biliary tree represented the main secretory unit of the liver. On the basis of
measurement of electrolyte excretion in dog bile, Wheeler et al.
(156) identified two distinct anatomic secretory sites,
one responsible for bile acid-dependent bile flow and one (more distal) important for the choleretic effect of secretin. In support of the
secretory capacity of the ductal epithelium, studies in dogs and
rabbits have shown secretion of water and electrolytes by an isolated
segment of the extrahepatic bile duct in situ (103, 131)
and in vitro (40). Studies in dogs with bile fistula
(155) and isolated, perfused pig liver (66)
have shown that secretin increases bicarbonate-rich bile secretion and
that the increase in bile flow is proportional to the logarithm of the
dose of secretin. Furthermore, studies in isolated, perfused pig liver
demonstrated that the electrolyte composition of the fraction of bile
stimulated by secretin is independent of the bile flow before secretin
administration in the perfused preparation (67). Other
studies in dogs have shown that 1) infusion of secretin
via the hepatic artery [the major blood supply of the
intrahepatic biliary epithelium (37, 115)] induced
greater choleresis compared with secretin infusion through the splenic
vein and 2) the biliary tree volume was smaller during
secretin choleresis compared with taurocholate-induced choleresis
(154). These studies suggest that secretin-stimulated bicarbonate-rich bile flow derives from the interaction of this hormone
with intrahepatic bile ducts rather than hepatocytes. However, other
studies have shown that interruption of blood flow to the intrahepatic
biliary epithelium (by short-term ligation of the hepatic artery of
guinea pigs) does not alter cholangiocyte secretory activity
(142). Radiolabeled mannitol and erythritol (used with the
assumption that these carbohydrates are transported across the bile
canaliculus but not the biliary epithelium) have been used to define
the anatomic site of secretin-induced choleresis in guinea pigs
(55). However, recent studies in rats (128) and guinea pigs (141) have questioned the use of these two
molecules (to distinguish between hepatocyte and cholangiocyte bile
secretion), because they can cross the intrahepatic biliary epithelium.
For example, erythritol is not an ideal marker of canalicular bile flow
because it has been shown to cross the rat intrahepatic ductal epithelium, possibly via intercellular junctions (128). In
vivo studies in humans, baboons, and dogs have also shown that
intravenous infusion of secretin increases bile flow (87).
These studies also showed that secretin-induced choleresis is
associated with an increase in cAMP levels in extrahepatic bile duct
tissue in humans and baboons (but not dogs), suggesting that cAMP may
be a second messenger system for secretin (87). Conclusive
evidence for the role of secretin in directly stimulating ductal
secretion came from recent studies (2, 3, 10, 11, 76)
showing that in vivo secretin induces a massive bicarbonate-rich
choleresis [usually absent under normal conditions (10, 11, 63,
84, 143)] in rats with enhanced intrahepatic ductal mass
induced by BDL (2, 3, 10, 11), cirrhosis
(76), and chronic -naphthylisothiocyanate (ANIT)
feeding (11, 32). Secretin-stimulated choleresis results
from the direct interaction of secretin with secretin receptors [SR;
exclusively expressed by cholangiocytes in rat liver (15,
53)]. The interaction of secretin with its receptors induces an
increase in intracellular cAMP levels (6, 9, 13, 14, 62, 63, 75,
83-86, 143) and activation of the Cl
channel
cystic fibrosis transmembrane regulator (CFTR), with subsequent
activation of the Cl
/HCO
|
![]() |
EXPERIMENTAL TOOLS FOR EVALUATING SECRETIN-STIMULATED DUCTAL SECRETION |
---|
In Vivo Models of Cholangiocyte Hyperplasia/Ductopenia
Recently, a number of animal models of ductal hyperplasia [inducing an increase in the number of intrahepatic bile ducts (7, 10, 11, 62, 83, 84) or loss of cholangiocytes (85, 86)] have been developed and have allowed us to increase our knowledge of the role and mechanisms of action of secretin in the regulation of ductal secretion (Refs. 7, 10-13, 15, 62, 63, 76, 83-86, 88, 143; see Table 2). Rodent models of cholangiocyte hyperplasia include partial hepatectomy (84), chronic feeding of bile acids [i.e., taurocholate (TC) and taurolithocholate (TLC); Ref. 7] or ANIT (11, 32), cirrhosis [induced by chronic administration of phenobarbital in conjunction with CCl4 to rats (76) or chronic CCl4 treatment in mice (4)], experimental fascioliasis (88), and BDL (9, 10) (Table 2). These models of duct hyperplasia are closely associated with increased secretin-stimulated ductal secretion evidenced by 1) increased SR gene expression (7, 9, 14, 15, 63, 84), secretin-stimulated cAMP levels (7, 9, 14, 62, 63, 84, 143), and ClAnimal models of ductopenia [i.e., total vagotomy (83)] or liver toxins [i.e., CCl4 (85, 86)] result in a decrease or loss of secretin-stimulated ductal secretion. Interruption of the cholinergic innervation (by total vagotomy of BDL rats) inhibits SR gene expression, secretin-stimulated cAMP levels, and secretin-induced bile flow and bicarbonate secretion (83). Maintenance of cAMP levels by chronic forskolin administration to BDL rats prevents the inhibitory effects of vagotomy on secretin-stimulated cholangiocyte secretion (83). In rats, the toxin CCl4 has been shown to selectively damage large cholangiocytes (with loss of secretin-stimulated secretory responses), whereas small cholangiocytes are resistant to CCl4-induced duct damage and, de novo, express SR and respond physiologically to secretin to compensate for the loss of secretin-induced secretion of large ducts (85, 86).
In Vitro Tools
A major advancement in the understanding of the role and mechanisms of action of secretin in the regulation of ductal secretion came from the development of sophisticated techniques [e.g., immunoaffinity separation (71, 75) and micropipetting (6, 100, 119)] for the isolation and phenotypic characterization of pure preparations of pooled small and large cholangiocytes and intrahepatic bile duct units (IBDU) from normal and cholestatic rat liver (6, 10, 11, 13, 45, 62, 63, 71, 75, 83, 84, 143). Isolated cholangiocytes and IBDU have allowed us to evaluate the effect of secretin on cAMP levels (6, 9, 13, 14, 16, 62, 63, 75, 83-86, 98, 143), protein kinase A (PKA) activity (16, 98), Cl ![]() |
SECRETIN RECEPTOR |
---|
Secretin receptors belong to a unique family of G protein-coupled receptors including receptors for VIP, pituitary adenylate cyclase-activating polypeptide, gastric inhibitory peptide, glucagon, glucagon-like peptide 1, calcitonin, calcitonin gene-related peptide, parathyroid hormone, growth hormone-releasing factor, and corticotropin-releasing factor (148). All the members of this peptide family possess a remarkable amino acid sequence homology and bind to G protein-coupled receptors, whose signaling mechanism primarily involves adenylyl cyclase and/or PKA (148). These receptors share homology with each other, indicating that all originate from a common ancestral sequence through gene duplication (148). SR has seven transmembrane-spanning helical domains separating loop and tail domains (25). The SR extracellular domains contain sites for asparagine-linked glycosylation and a pair of cysteine residues linking the first and second extracellular loops through a disulfide bond (25). The confluence of the transmembrane helices and the extracellular loops contribute to secretin binding to SR (25). The SR intracellular domains include domains for G protein binding and sites for phosphorylation (126). The SR (prototypic of the class II family of G protein-coupled receptors) contains a long extracellular amino-terminal domain containing six highly conserved Cys residues and one Cys residue [Cys(11)] (25). Recent studies have identified the specific structural and functional domain of the secretin and its receptor (113). These studies have shown that the amino-terminal 15 residues of secretin are critical for the stimulation of SR (113). The studies have also shown that the amino terminus of the SR is necessary, but not sufficient, requiring the complementation of an extracellular loop domain for the physiological response to secretin (113). Secretin binding to the extracellular domain of SR results in coupling with heterotrimeric G proteins at a cytosolic domain of SR (58).
The G proteins consist of -,
-, and
-subunits
(114). G proteins are members of a superfamily of GTPases
that are fundamentally conserved from bacteria to mammals and play a
role in many aspects of cell regulation (114).
Ligand-bound SR activates G proteins, which in turn activate adenylyl
cyclase, leading to increased intracellular cAMP accumulation
(114). Characterization of hormone-binding domains of SR
and SR cloning and expression is beyond the scope of this review and
has been recently discussed in detail elsewhere (148).
Recently, the cDNA for the human (47), rat (70), and rabbit (138) SR gene has been cloned and functionally characterized. SR is widely distributed in the body including brain, heart, stomach, intestine, and pancreas (33, 57, 60, 70). In the liver, in situ autoradiographic studies of liver sections (53) and in vitro studies in purified cholangiocytes (15) and cholangiocyte membranes (52) have shown that SR are exclusively expressed on the basolateral membrane of rat cholangiocytes.
![]() |
MECHANISMS OF SECRETIN-REGULATED DUCTAL SECRETION |
---|
Secretin stimulates ductal secretion by a series of sequential and
coordinated events (6, 10-16, 18, 22, 54, 63, 75, 84, 134,
143). First, secretin interacts with basolateral SR
(95), expressed only by cholangiocytes in rat liver
(15, 53). This interaction induces elevation of cytosolic
cAMP levels, activation of intracellular PKA (22, 41), and
opening of the cAMP-dependent Cl channels by
phosphorylation (41), leading to extrusion of
Cl
ions with subsequent depolarization of the cell
membrane (54, 98) (Fig. 1). Opening of Cl
channels (14, 54, 98) induces a Cl
gradient
favoring the activation of the apically located
Cl
/HCO
efflux, and this causes the entry of
HCO
/HCO
/HCO
/HCO
/HCO
/HCO
conductance. Other studies in
pigs (64, 150) have proposed the role of
H+-ATPase in the regulation of ductal secretion, because
H+-ATPase is inserted into the basolateral cholangiocyte
membrane in response to secretin, thus working as an acid extruder.
However, recent studies in rats have shown that intrahepatic IBDU do
not express H+-ATPase (44).
Recent studies have shown that the PKA system regulates secretin-stimulated bicarbonate-enriched ductal secretion (22). These studies have shown that Sp-adenosine 3',5'-cyclic monophosphothiolate (Sp-cAMPS), a PKA-specific agonist, stimulates ductal bicarbonate secretion, whereas Rp-cAMPS, a specific PKA inhibitor, decreases secretin-stimulated ductal bicarbonate secretion (22). The data suggest that secretin-induced choleresis is regulated, at the level of CFTR, by a balance between the activities of kinases [inducing activation (22)] and phosphatases [causing inactivation (17)].
Other studies in rat cholangiocytes have shown that secretin stimulates insertion of transporters into the apical membrane of cholangiocytes via a cAMP-dependent but cGMP-, D-myo-inositol 1,4,5-trisphosphate (IP3)-, and Ca2+-independent mechanism (75, 143).
The transport of water to ductal bile is regulated by membrane
aquaporin water channels (AQP) present in both the basolateral and
apical domains of rat (93, 95, 108, 121) and human
(107) intrahepatic cholangiocytes. In a fashion similar to
the urinary system, in which aquaporin activity in the collecting
tubule and bladder epithelium is modulated by vasopressin
(149), membrane water channels are also regulated in the
rat intrahepatic biliary epithelium (93, 95). In rats,
secretin increases water channel activity in the cholangiocyte apical
membrane by stimulating the movement of latent inactive AQP1
(associated with internal cholangiocyte cytoplasmic vesicles) to the
cholangiocyte apical membrane, where they become active water channels
(93, 95). Secretin-stimulated AQP1 insertion into rat
cholangiocyte apical membrane is microtubule dependent because it is
inhibited by pretreatment of cholangiocytes with colchicine (but not
with its inactive analog -lumicolchicine). These studies
demonstrated that secretin-induced secretion of water and electrolytes
is dependent on activation of latent AQP1 in rat cholangiocytes
(93, 95). Recent studies have also localized AQP4 in the
basolateral membrane of rat cholangiocytes (94). In
contrast to AQP1, which is targeted to the apical cholangiocyte membrane by secretin (93, 95), AQP4 is not regulated by
secretin (94). AQP4 may be important in facilitating
basolateral transport of water in cholangiocytes, an important step in
the regulation of bile secretion. Recent studies in Xenopus
oocytes injected with CFTR demonstrated the presence of CFTR in
vesicles and cAMP-dependent (by forskolin treatment) membrane insertion
of these CFTR-containing vesicles (139). The apical
membrane insertion of CFTR from these vesicles may provide a link
between activation of CFTR and cAMP-dependent (by secretin activation)
regulation of ductal secretion of water and electrolytes.
![]() |
FACTORS REGULATING SECRETIN-STIMULATED DUCTAL SECRETION |
---|
Parasympathetic Innervation
In the liver, sympathetic and parasympathetic innervation originate from the celiac ganglion (sympathetic) and from the vagus nerve (parasympathetic) (116, 147) and innervate the hepatic artery, the portal vein, the intrahepatic and extrahepatic biliary epithelium, and parenchymal cells (116, 147). Recent studies in rats have shown that the parasympathetic system regulates secretin-stimulated ductal secretion (16, 106). Nathanson et al. (106) demonstrated that ACh elicits both Ca2+ increase and oscillation in rat IBDU and isolated cholangiocytes because of both influx of extracellular Ca2+ and mobilization of thapsigargin-sensitive Ca2+ stores. Other studies have shown that intrahepatic parasympathetic terminations release ACh, which interacts selectively with M3 ACh receptors on cholangiocytes, inducing an increase in secretin-stimulated cholangiocyte cAMP synthesis and ClAlkaline Phosphatase
AP is a nonspecific protein phosphatase whose precise function is unknown. Elevated serum AP levels are observed in cholestatic liver diseases (10, 123). Cholangiocytes are continuously exposed at their apical membrane to high concentrations of AP in bile (74, 78). Recently, the effects of acute and chronic administration of AP on secretin-stimulated ductal secretion were evaluated in vivo in rats with bile fistula and in vitro in purified rat IBDU (17). In vivo, acute and chronic administration of AP decreased both basal and secretin-stimulated bile flow and biliary bicarbonate secretion in BDL rats (17). In vitro, basal and secretin-stimulated ClGastrointestinal Hormones
Gastrin.
Gastrin modulates the functions of several epithelia by interaction
with CCK-B/gastrin receptors through Ca2+-,
IP3-, and protein kinase C (PKC)-dependent mechanisms (see Fig. 2) (159, 160). In the
liver, gastrin inhibits secretin-stimulated ductal secretion of BDL
rats at the physiological doses of
109-10
7 M (63). The
presence of an inhibitory effect of gastrin on secretin-induced ductal
secretion at a physiological dose [blood gastrin concentration of
10
9-10
10 M in rats (82)]
supports the presence of specific, physiologically relevant receptors
for gastrin on cholangiocytes. We suggest that gastrin [similar to
somatostatin (9, 143)] may be physiologically important
in the regulation of enhanced secretin-stimulated ductal secretion in
cholestatic liver diseases by counterpoising the stimulatory effects of
secretin. The inhibitory effect of gastrin on secretin-stimulated
ductal secretion occurs through activation and membrane translocation
of the Ca2+-dependent PKC-
(62). These data
suggest that cross-talk between the cAMP/PKA system [by which secretin
stimulates ductal secretion (9, 16, 62, 63, 84-86)]
and the IP3/PKC system [by which gastrin inhibits
secretion and proliferation (62, 159, 160)] may play an
important role in the regulation of overall cholangiocyte secretory
activity.
|
Somatostatin.
Studies in dogs (117) and in rats (118, 143)
showed that somatostatin inhibits both basal and secretin-stimulated
bicarbonate-rich choleresis by inhibition of exocytic vesicle insertion
into cholangiocyte apical membranes (Refs. 75 and 143;
Fig. 2) through interactions with a subtype (i.e., SSTR2)
of somatostatin receptors (143). These studies also showed
that secretin-stimulated insertion of transporters into the apical
membrane of rat cholangiocytes is dependent on the microtubule system
because it is inhibited by pretreatment of cholangiocytes with
colchicine (75, 143). In rats, somatostatin inhibition of
secretin-stimulated ductal secretion is also associated with decreased
SR gene expression (9) and decreased secretin-stimulated
cAMP levels (9, 143). The inhibitory effect of
somatostatin on secretin-stimulated ductal secretion is more evident in
animal models of ductal hyperplasia (e.g., BDL), in which there is
upregulation of SR and enhanced secretin-stimulated cAMP levels. On the
basis of these findings (75, 143), the "membrane
microdomain recycling model" (Fig. 3)
has been proposed in rat liver to explain the cooperative interactions
between secretin and somatostatin in the regulation of ductal secretory
activity. In contrast to these findings, other studies in rats showed
that colchicine does not inhibit secretin-induced ductal secretion, thus providing evidence against a pivotal role of exocytic vesicle insertion into cholangiocyte apical membrane to explain the choleretic effect of secretin (49).
|
Peptides
Endothelin. ET-1, a polypeptide containing 21 amino acids, has multifunctional properties in several organs (127). Recent studies in rats showed that ET-1 receptors ETA and ETB are expressed by cholangiocytes and that ET-1 inhibits SR gene expression, secretin-stimulated ductal lumen expansion, and secretin-induced cAMP levels by selective interaction with ETA but not ETB receptors (38). Furthermore, studies in primary cultures of human gallbladder epithelial cells showed that ET-1, via a Gi protein-coupled receptor, inhibits secretin-stimulated cAMP-dependent electrolyte secretion (56).
Vasoactive intestinal peptide. In vivo studies in humans showed that VIP potentiates the choleretic effect of secretin on bile flow and bicarbonate secretion (110, 111). Variation among species may explain the different cooperative interactions between VIP and secretin in the regulation of ductal bile secretion (43, 65, 92). In dogs, for example, VIP stimulated basal biliary secretion but did not alter the maximal effect of secretin on ductal secretion (92). In sheep liver, whereas secretin stimulated bile flow, VIP had no effect on ductal secretion (65). Although VIP regulates secretory activity of other epithelia through the cAMP/PKA (35, 102) or IP3/PKC pathway (130), recent studies in rats showed that VIP stimulates basal (but not secretin-stimulated) fluid and bicarbonate secretion via cAMP-independent pathways in IBDU (43). Together, the data suggest that VIP regulates basal and [possibly secretin stimulated (110, 111)] ductal secretion through a signaling pathway different from that of secretin.
Bombesin.
In support of a possible interaction between bombesin and secretin,
Kaminski and Deshpande (72) showed in dogs that bombesin markedly increases the bicarbonate-rich choleresis produced by intraduodenal acid infusion through increased secretin release. Recent
studies in rats showed that bombesin increases ductal secretion and
that bombesin stimulation of Cl/HCO
and K+ channels, and
carbonic anhydrase but not microtubules (46), through
mechanisms different from those established for secretin (6,
9-18, 22, 38, 62, 63, 83-87, 98, 143).
Substance P. Studies in rats showed that substance P decreases basal and secretin-stimulated secretion of pancreatic ducts (24). Similarly, in vivo studies in dogs showed that substance P inhibits secretin-stimulated choleresis (91). In contrast to these observations, preliminary studies in rat IBDU showed that substance P does not alter the effect of secretin on water and electrolyte secretion (21).
Bile Acids
A number of studies in rats showed that certain bile acids enter cholangiocytes through the Na+-dependent apical bile acid transporter (ABAT) (8, 80), thus modifying secretin-stimulated ductal bile secretion (5, 7, 8). For example, recent studies showed that TC and TLC increased in vitro (5) and in vivo (after chronic feeding) (7) secretin SR gene expression, secretin-stimulated cAMP levels, and secretin-stimulated bicarbonate-rich choleresis of normal rats.Nitric Oxide
Recent studies by Trauner et al. (146) demonstrated that nitric oxide and cGMP, which stimulate secretion of rat hepatocyte couplets, do not alter basal or secretin-stimulated ductal lumen volume and ClCytokines
A number of studies indicate that the intrahepatic cholangiocytes and peribiliary gland in normal human livers and in hepatolithiasis are involved in local immunological responses through the transport of secretory component and IgA into bile (137). Human cholangiocytes also express ICAM-1 (26, 48), lymphocyte function-associated antigen (LFA)-3 (48), CD40 (48), and human lymphocyte antigen (HLA) class 1 (26, 48). Human cholangiocytes secrete interleukin (IL)-6 and tumor necrosis factor- ![]() |
HETEROGENEITY OF SECRETIN-INDUCED CHOLANGIOCYTE RESPONSES |
---|
Recently, the isolation and phenotypic characterization of
distinct subpopulations of small (~8 µm in size) and large (~13 µm in size) cholangiocytes (13, 14) and small (<15 µm
in external diameter) and large (>15 µm in external diameter) IBDU
(6) allowed us to demonstrate that the intrahepatic
biliary epithelium is morphologically and functionally heterogeneous
(5, 6, 8, 13, 14, 85, 86). These studies showed that the
SR is solely expressed by large cholangiocytes in large ducts (6, 13), which respond physiologically to secretin with increases in
cAMP levels, Cl efflux, and
Cl
/HCO
/HCO
|
![]() |
SUMMARY AND FUTURE PERSPECTIVES |
---|
The findings discussed in this review emphasize that secretin-stimulated ductal bile secretion is cooperatively regulated by a number of factors, some with stimulatory effects [e.g., VIP, ACh, the bile acids TC and TLC (5, 7, 16)] and some with inhibitory action [e.g., somatostatin, gastrin, ET-1, AP (9, 17, 38, 63, 143)]. The recent data related to the role and mechanisms of action of ACh (16) and bile acids (5, 7) are the most interesting findings related to the modulation of secretin-stimulated ductal secretion. The findings that rat cholangiocytes of different sizes differentially respond to liver injury and/or toxins has clinical relevance because a number of chronic cholestatic liver diseases (e.g., PBC and PSC) are characterized by a spotty rather than a diffuse proliferative response (12, 120). Studies are needed to evaluate the role and mechanisms of action of the adrenergic and dopaminergic nerves in the regulation of secretin-stimulated bicarbonate-rich choleresis. Taking into account that after BDL microvascular proliferation occurs only adjacent to large proliferating ducts (59) and that secretin-stimulated secretion is only present in large cholangiocytes (9, 13, 14, 85, 86), further studies are necessary to understand the role of blood supply and vascularly derived factors in the regulation of secretin-stimulated ductal bile secretion. On the basis of these findings, it seems likely that our understanding of secretin stimulation of ductal secretory functions will continue to grow as a focus of increasing attention and importance.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr. Domenico Alvaro (University of the Studies of Rome, La Sapienza, Rome, Italy) for his suggestions during the preparation of this review.
![]() |
FOOTNOTES |
---|
Some of the work presented here was supported by a grant award to G. LeSage and G. Alpini from Scott & White Hospital and Texas A&M University, by an American Association for the Studies of Liver Diseases/Schering Advanced Hepatology Fellowship Program grant to N. Kanno, by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK-54208 to G. LeSage, by a Department of Veterans Affairs Merit Award and NIDDK Grant DK-58411 to G. Alpini, and by a grant award from Scott & White Hospital to S. Glaser.
Address for reprint requests and other correspondence: G. Alpini, Depts. of Internal Medicine and Medical Physiology, Texas A&M Univ. System Health Science Center, College of Medicine, Central Texas Veterans HSC MRB, 702 South West H.K. Dodgen Loop, Temple, TX, 76504 (E-mail: galpini{at}tamu.edu).
![]() |
REFERENCES |
---|
1.
Abbott, WA,
and
Meister A.
Intrahepatic transport and utilization of biliary glutathione and its metabolites.
Proc Natl Acad Sci USA
83:
1246-1250,
1986[Abstract].
2.
Accatino, L,
Contreras A,
Berdichevsky E,
and
Quintana C.
The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat.
J Lab Clin Med
97:
525-534,
1981[ISI][Medline].
3.
Accatino, L,
Contreras A,
Fernandez S,
and
Quintana C.
The effect of complete biliary obstruction on bile flow and bile acid excretion: postcholestatic choleresis in the rat.
J Lab Clin Med
93:
706-717,
1979[ISI][Medline].
4.
Alpini, G,
Elias I,
Glaser S,
Rodgers R,
Phinizy J,
Robertson W,
Francis H,
Lasater J,
Richards M,
and
LeSage G.
Gamma interferon inhibits cholangiocyte proliferation and secretin-induced ductal secretion in a novel murine model of cirrhosis.
J Hepatol
27:
371-380,
1997[ISI][Medline].
5.
Alpini, G,
Glaser S,
Robertson W,
Phinizy JL,
Rodgers R,
Caligiuri A,
and
LeSage G.
Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
273:
G518-G529,
1997
6.
Alpini, G,
Glaser S,
Robertson W,
Rodgers R,
Phinizy JL,
Lasater J,
and
LeSage GD.
Large but not small intrahepatic bile duct units are involved in secretin-regulated ductal bile secretion in normal rat liver.
Am J Physiol Gastrointest Liver Physiol
272:
G1064-G1074,
1997
7.
Alpini, G,
Glaser S,
Ueno Y,
Phinizy JL,
Rodgers R,
Francis H,
Baiocchi L,
Holcomb L,
Caligiuri A,
and
LeSage G.
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion.
Gastroenterology
116:
179-186,
1999[ISI][Medline].
8.
Alpini, G,
Glaser SS,
Rodgers R,
Phinizy JL,
Robertson WE,
Lasater J,
Caligiuri A,
Tretjak Z,
and
LeSage GD.
Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes.
Gastroenterology
113:
1734-1740,
1997[ISI][Medline].
9.
Alpini, G,
Glaser SS,
Ueno Y,
Pham L,
Podila PV,
Caligiuri A,
LeSage G,
and
LaRusso NF.
Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation.
Am J Physiol Gastrointest Liver Physiol
274:
G767-G775,
1998
10.
Alpini, G,
Lenzi R,
Sarkozi L,
and
Tavoloni N.
Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules.
J Clin Invest
81:
569-578,
1988[ISI][Medline].
11.
Alpini, G,
Lenzi R,
Zhai W-R,
Slott PA,
Liu MH,
Sarkozi L,
and
Tavoloni N.
Bile secretory function of intrahepatic biliary epithelium in the rat.
Am J Physiol Gastrointest Liver Physiol
257:
G124-G133,
1989
12.
Alpini, G,
Phillips JO,
and
LaRusso NF.
The biology of the biliary epithelia.
In: The Liver: Biology and Pathobiology (3rd ed.), edited by Arias I,
Boyer JL,
Fausto N,
Jakoby W,
Schachter D,
and Shafritz DA.. New York: Raven, 1994, p. 623-653.
13.
Alpini, G,
Roberts SK,
Kuntz SM,
Ueno Y,
Gubba S,
Podila P,
LeSage G,
and
LaRusso NF.
Morphological, molecular and functional heterogeneity of cholangiocytes from normal rat liver.
Gastroenterology
110:
1636-1643,
1996[ISI][Medline].
14.
Alpini, G,
Ulrich C,
Roberts S,
Phillips JO,
Ueno Y,
Podila PV,
Colegio O,
LeSage GD,
Miller LJ,
and
LaRusso NF.
Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation.
Am J Physiol Gastrointest Liver Physiol
272:
G289-G297,
1997
15.
Alpini, G,
Ulrich C, II,
Phillips J,
Pham L,
Miller L,
and
LaRusso N.
Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation.
Am J Physiol Gastrointest Liver Physiol
266:
G922-G928,
1994
16.
Alvaro, D,
Alpini G,
Jezequel AM,
Bassotti C,
Francis C,
Fraioli F,
Romeo R,
LeSage G,
Glaser S,
and
Benedetti A.
Role and mechanisms of acetylcholine in the regulation of cholangiocyte secretory functions.
J Clin Invest
100:
1349-1362,
1997
17.
Alvaro, D,
Benedetti A,
Marucci L,
Delle Monache M,
Papa E,
DiCosimo E,
Perego L,
Macarri G,
Glaser S,
LeSage G,
and
Alpini G.
The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat.
Hepatology
32:
174-184,
2000[ISI][Medline].
18.
Alvaro, D,
Cho WKC,
Mennone A,
and
Boyer JL.
Effect of secretin on intracellular pH regulation in isolated rat bile duct epithelial cells.
J Clin Invest
92:
1314-1325,
1993[ISI][Medline].
19.
Alvaro, D,
Gigliozzi A,
and
Attili AF.
Regulation and deregulation of cholangiocyte proliferation.
J Hepatol
33:
333-340,
2000[ISI][Medline].
20.
Alvaro, D,
Gigliozzi A,
Fraioli F,
Romeo R,
Papa E,
Delle Monache M,
and
Capocaccia L.
Hormonal regulation of bicarbonate secretion in the biliary epithelium.
Yale J Biol Med
70:
417-426,
1997[ISI][Medline].
21.
Alvaro, D,
Gigliozzi A,
LaRosa T,
Carli L,
Furfaro S,
Fraioli F,
Francia C,
Romeo R,
and
Capocaccia L.
Hormonal regulation of electrolyte transport in biliary epithelial cells.
In: International Falk Workshop. Vanishing Bile Duct Syndrome. Pathophysiology and Treatment, edited by Alvaro D,
Benedetti A,
and Strazzabosco M.. Dordrecht: Kluwer Academic, 1997, p. 52-64.
22.
Alvaro, D,
Mennone A,
and
Boyer JL.
Role of kinases and phosphatases in the regulation of fluid secretion and Cl/HCO
23.
Andrews, WHH
Excretory function of the liver. A re-assessment.
Lancet
2:
166-169,
1955[ISI].
24.
Ashton, N,
Argent BE,
and
Green R.
Effect of vasoactive intestinal peptide, bombesin and substance P on fluid secretion by isolated rat pancreatic ducts.
J Physiol (Lond)
427:
471-482,
1990[Abstract].
25.
Asmann, YW,
Dong M,
Ganguli SC,
Hadac EM,
and
Miller LJ.
Structural insights into the amino-terminus of the secretin receptor. I. Status of cysteine and cystine residues.
Mol Pharmacol
58:
911-919,
2000
26.
Ayres, RC,
Neuberger JM,
Shaw J,
Joplin R,
and
Adams DH.
Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines.
Gut
34:
1245-1249,
1993[Abstract].
27.
Baiocchi, L,
LeSage G,
Glaser S,
and
Alpini G.
Regulation of cholangiocyte bile secretion.
J Hepatol
31:
179-191,
1999[ISI][Medline].
28.
Bayliss, WM,
and
Starling EH.
The mechanism of pancreatic secretion.
J Physiol (Lond)
28:
325-348,
1902.
29.
Beijer, HJ,
Hulstaert PF,
Brouwer FA,
and
Charbon GA.
The effect of secretin on peripheral arterial blood flow.
Arch Int Pharmacodyn Ther
240:
269-277,
1979[ISI][Medline].
30.
Beinborn, M,
Quinn SM,
and
Kopin AS.
Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties.
J Biol Chem
273:
14146-14151,
1998
31.
Benedetti, A,
Bassotti C,
Rapino K,
Marucci L,
and
Jezequel AM.
A morphometric study of the epithelium lining the rat intrahepatic biliary tree.
J Hepatol
24:
335-342,
1996[ISI][Medline].
32.
Bhathal, PS,
and
Gall JA.
Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus.
Liver
5:
311-325,
1985[ISI][Medline].
33.
Bissonnette, BM,
Collen MJ,
Adachi H,
Jensen RT,
and
Gardner JD.
Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini.
Am J Physiol Gastrointest Liver Physiol
246:
G710-G717,
1984
34.
Boyer, JL.
Bile duct epithelium: frontiers in transport physiology.
Am J Physiol Gastrointest Liver Physiol
270:
G1-G5,
1996
35.
Bryant, MG,
Polak MM,
Modlin I,
Bloom SR,
Albuquerque RH,
and
Pearse AG.
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.
Lancet
1:
991-993,
1976[ISI][Medline].
36.
Buanes, T,
Grotmol T,
Veel T,
Landsverk T,
Ridderstrale Y,
and
Raeder MG.
Importance of carbonic anhydrase for canalicular and ductular choleresis in the pig.
Acta Physiol Scand
133:
535-544,
1988[ISI][Medline].
37.
Burkel, WE.
The fine structure of the terminal branches of the hepatic arterial system of the rat.
Anat Rec
167:
329-49,
1970[ISI][Medline].
38.
Caligiuri, A,
Glaser S,
Rodgers R,
Phinizy JL,
Robertson W,
Papa E,
Pinzani M,
and
Alpini G.
Endothelin 1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
275:
G835-G846,
1998
39.
Charlton, CG,
Miller RL,
Crawley JN,
Handelmann GE,
and
O'Donohue TL.
Secretin modulation of behavioral and physiological functions in the rat.
Peptides
4:
739-742,
1983[ISI][Medline].
40.
Chenderovitch, J.
Secretory function of the rabbit common bile duct.
Am J Physiol
223:
695-706,
1972[ISI][Medline].
41.
Cheng, SH,
Rich DP,
Marshall J,
Gregory RJ,
Welsh MJ,
and
Smith AE.
Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.
Cell
66:
1027-1036,
1991[ISI][Medline].
42.
Chey, WY,
and
Escoffery R.
Secretion cells in the gastrointestinal tract.
Endocrinology
98:
1390-1395,
1976[Abstract].
43.
Cho, WK,
and
Boyer JL.
Vasoactive intestinal polypeptide is a potent regulator of bile secretion from rat cholangiocytes.
Gastroenterology
117:
420-428,
1999[ISI][Medline].
44.
Cho, WK,
Mennone A,
and
Boyer JL.
Intracellular pH regulation in bombesin-stimulated secretion in isolated bile duct units from rat liver.
Am J Physiol Gastrointest Liver Physiol
275:
G1028-G1036,
1998
45.
Cho, WK,
Mennone A,
and
Boyer JL.
Isolation of functional polarized bile duct units from mouse liver.
Am J Physiol Gastrointest Liver Physiol
280:
G241-G246,
2001
46.
Cho, WK,
Mennone A,
Rydberg SA,
and
Boyer JL.
Bombesin stimulates bicarbonate secretion from rat cholangiocytes: implications for neural regulation of bile secretion.
Gastroenterology
113:
311-321,
1997[ISI][Medline].
47.
Chow, BK.
Molecular cloning and functional characterization of a human secretin receptor.
Biochem Biophys Res Commun
212:
204-211,
1995[ISI][Medline].
48.
Cruickshank, SM,
Southgate J,
Selby PJ,
and
Trejdosiewicz LK.
Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro.
J Hepatol
29:
550-558,
1998[ISI][Medline].
49.
Dallenbach, A,
and
Renner EL.
Colchicine does not inhibit secretin-induced choleresis in rats exhibiting hyperplasia of bile ductules: evidence against a pivotal role of exocytic vesicle insertion.
J Hepatol
22:
338-348,
1995[ISI][Medline].
50.
Eisenmann-Tappe, I,
Wizigmann S,
and
Gebhardt R.
Glutamate uptake in primary cultures of biliary epithelial cells from normal rat liver.
Cell Biol Toxicol
7:
315-325,
1991[ISI][Medline].
51.
Elsing, C,
Kassner A,
Hubner C,
Buhli H,
and
Stremmel W.
Absorptive and secretory mechanisms in biliary epithelial cells.
J Hepatol
24:
121-127,
1996[ISI][Medline].
52.
Farouk, M,
Vigna SR,
Haebig JE,
Gettys TW,
McVey DC,
Chari R,
Pruthi RS,
and
Meyers WC.
Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium.
J Surg Res
54:
1-6,
1993[ISI][Medline].
53.
Farouk, M,
Vigna SR,
McVey DC,
and
Meyers WC.
Localization and characterization of secretin binding sites expressed by rat bile duct epithelium.
Gastroenterology
102:
963-968,
1992[ISI][Medline].
54.
Fitz, JG,
Basavappa S,
McGill J,
Melhus O,
and
Cohn JA.
Regulation of membrane chloride currents in rat bile duct epithelial cells.
J Clin Invest
91:
319-328,
1993[ISI][Medline].
55.
Forker, EL.
Two sites of bile formation as determined by mannitol and erythritol clearance in the guinea pig.
J Clin Invest
46:
1189-1195,
1967[ISI][Medline].
56.
Fouassier, L,
Chinet T,
Robert B,
Carayon A,
Balladur P,
Mergey M,
Paul A,
Poupon R,
Capeau J,
Barbu V,
and
Housset C.
Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate-dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cells.
J Clin Invest
101:
2881-2888,
1998
57.
Fremeau, RTJ,
Jensen RT,
Charlton CG,
Miller RL,
O'Donohue TL,
and
Moody TW.
Secretin: specific binding to rat brain membranes.
J Neurosci
3:
1620-1625,
1983[Abstract].
58.
Ganguli, SC,
Park CG,
Holtmann MH,
Hadac EM,
Kenakin TP,
and
Miller LJ.
Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis.
J Pharmacol Exp Ther
286:
593-598,
1998
59.
Gaudio, E,
Onori P,
Pannarale L,
and
Alvaro D.
Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study.
Gastroenterology
111:
1118-1124,
1996[ISI][Medline].
60.
Gespach, C,
Bataille D,
Vauclin N,
Moroder L,
Wunsch E,
and
Rosselin G.
Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology.
Peptides
7, Suppl 1:
155-163,
1986[ISI][Medline].
61.
Gigliozzi, A,
Fraioli F,
Sundaram P,
Lee J,
Mennone A,
Alvaro D,
and
Boyer JL.
Molecular identification and functional characterization of mdr1a in rat cholangiocytes.
Gastroenterology
119:
1113-1122,
2000[ISI][Medline].
62.
Glaser, S,
Benedetti A,
Marucci L,
Alvaro D,
Baiocchi L,
Kanno N,
Caligiuri A,
Phinizy JL,
Chowdhury U,
Papa E,
LeSage G,
and
Alpini G.
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/gastrin receptors via D-myo-inositol 1,4,5-trisphosphate-, Ca2+-, and PKC-dependent mechanisms.
Hepatology
32:
17-25,
2000[ISI][Medline].
63.
Glaser, SS,
Rodgers R,
Phinizy JL,
Robertson WE,
Lasater J,
Caligiuri A,
Tretjak Z,
LeSage G,
and
Alpini G.
Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
273:
G1061-G1070,
1997
64.
Grotmol, T,
Buanes T,
Veel T,
and
Raeder MG.
Secretin-dependent HCO
65.
Harada, E,
Niiyama M,
and
Syuto B.
Hepatic bile and pancreatic exocrine secretions evoked by gastrointestinal peptides in sheep.
Comp Biochem Physiol A Physiol
85:
729-734,
1986[ISI].
66.
Hardison, WG,
and
Norman JC.
The effects of bile salts and secretin upon bile flow from the isolated perfused pig liver.
Gastroenterology
53:
412,
1967[ISI].
67.
Hardison, WG,
and
Norman JC.
Electrolyte composition of the secretin fraction from the perfused pig liver.
Am J Physiol
214:
758-763,
1968[ISI][Medline].
68.
Hubner, C,
Stremmel W,
and
Elsing C.
Sodium hydrogen exchange type 1 and bile ductular secretory activity in the guinea pig.
Hepatology
31:
562-571,
2000[ISI][Medline].
69.
Ip, NY,
and
Zigmond RE.
Synergistic effects of muscarinic agonists and secretin or vasoactive intestinal peptide on the regulation of tyrosine hydroxylase activity in sympathetic neurons.
J Neurobiol
42:
14-21,
2000[ISI][Medline].
70.
Ishihara, T,
Nakamura S,
Kaziro Y,
Takahashi T,
Takahashi K,
and
Nagata S.
Molecular cloning and expression of a cDNA encoding the secretin receptor.
EMBO J
10:
1635-1641,
1991[Abstract].
71.
Ishii, M,
Vroman B,
and
LaRusso NF.
Isolation and morphological characterization of bile duct epithelial cells from normal rat liver.
Gastroenterology
97:
1236-1247,
1989[ISI][Medline].
72.
Kaminski, DL,
and
Deshpande YG.
Effect of somatostatin and bombesin on secretin-stimulated ductular bile flow in dogs.
Gastroenterology
85:
1239-1247,
1983[ISI][Medline].
73.
Kanno, N,
LeSage G,
Glaser S,
Alvaro D,
and
Alpini G.
Functional heterogeneity of the intrahepatic biliary epithelium.
Hepatology
31:
555-561,
2000[ISI][Medline].
74.
Kaplan, MM,
and
Righetti A.
Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction.
J Clin Invest
49:
508-516,
1970[Medline].
75.
Kato, A,
Gores GJ,
and
LaRusso NF.
Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism.
J Biol Chem
267:
15523-15529,
1992
76.
Knuchel, J,
Krahenbuhl S,
Zimmermann A,
and
Reichen J.
Effect of secretin on bile formation in rats with cirrhosis of the liver; structure-function relationship.
Gastroenterology
97:
950-957,
1989[ISI][Medline].
77.
Komalavilas, P,
and
Lincoln TM.
Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta.
J Biol Chem
271:
21933-21938,
1996
78.
Komoda, T,
Kumegawa M,
Yajima T,
Tamura G,
and
Alpers DH.
Induction of rat hepatic and intestinal alkaline phosphatase activity produced by bile from bile duct-ligated animals.
Am J Physiol Gastrointest Liver Physiol
246:
G393-G400,
1984
79.
LaRusso, NF,
Ishii M,
and
Vroman BT.
The ins and outs of membrane movement in biliary epithelia.
Trans Am Clin Climatol Assoc
102:
245-259,
1991.
80.
Lazaridis, KN,
Pham L,
Tietz P,
Marinelli RA,
deGroen PC,
Levine S,
Dawson PA,
and
LaRusso NF.
Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter.
J Clin Invest
100:
2714-2721,
1997
81.
Lazaridis, KN,
Pham L,
Vroman B,
de Groen PC,
and
LaRusso NF.
Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
272:
G1168-G1174,
1997
82.
Lee, H,
Håkanson R,
Karlsson A,
Mattsson H,
and
Sundler F.
Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach.
Digestion
51:
125-132,
1992[ISI][Medline].
83.
LeSage, G,
Alvaro D,
Benedetti A,
Glaser S,
Marucci L,
Eisel W,
Caligiuri A,
Baiocchi L,
Rodgers R,
Phinizy JL,
Francis H,
and
Alpini G.
Cholinergic system modulates growth, apoptosis and secretion of cholangiocytes from bile duct ligated rats.
Gastroenterology
117:
191-199,
1999[ISI][Medline].
84.
LeSage, G,
Glaser S,
Gubba S,
Robertson WE,
Phinizy JL,
Lasater J,
Rodgers R,
and
Alpini G.
Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal bile secretion.
Gastroenterology
111:
1633-1644,
1996[ISI][Medline].
85.
LeSage, G,
Glaser S,
Marucci L,
Benedetti A,
Rodgers R,
Phinizy JL,
Holcomb L,
Caligiuri A,
Papa E,
Tretjak Z,
and
Alpini G.
Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from bile duct ligated rat liver.
Am J Physiol Gastrointest Liver Physiol
276:
G1289-G1301,
1999
86.
LeSage, GD,
Benedetti A,
Glaser S,
Marucci L,
Tretjak Z,
Caligiuri A,
Rodgers R,
Phinizy JL,
Baiocchi L,
Francis H,
Lasater J,
Ugili L,
and
Alpini G.
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver.
Hepatology
29:
307-319,
1999[ISI][Medline].
87.
Levine, RA,
and
Hall RC.
Cyclic AMP in secretin choleresis. Evidence for a regulatory role in man and baboons but not in dogs.
Gastroenterology
70:
537-544,
1976[ISI][Medline].
88.
Lopez, P,
Tunon MJ,
Gonzalez P,
Diez N,
Bravo AM,
and
Gonzalez-Gallego J.
Ductular proliferation and hepatic secretory function in experimental fascioliasis.
Exp Parasitol
77:
36-42,
1993[ISI][Medline].
89.
Ludwig, J.
New concepts in biliary cirrhosis.
Semin Liver Dis
7:
293-301,
1987[ISI][Medline].
90.
Madhu, C,
Mitchell DY,
and
Klaassen CD.
Effect of P-450 inducers on biliary excretion of glutathione and its hydrolysis products. Correlation between hepatic gamma-glutamyltranspeptidase activity and the proportion of glutathione hydrolysis products in bile.
Drug Metab Dispos
21:
342-349,
1993[Abstract].
91.
Magnusson, I,
Thulin L,
Einarsson K,
and
Bergstrom K.
Effects of substance P and somatostatin on taurocholate-stabilized and CCK- or secretin-induced choleresis in the anesthetized dog.
Scand J Gastroenterol
19:
1007-1014,
1984[ISI][Medline].
92.
Makhlouf, GM,
Yau WM,
Zfass AM,
Said SI,
and
Bodanszky M.
Comparative effects of synthetic and natural vasoactive intestinal peptide on pancreatic and biliary secretion and on glucose and insulin blood levels in the dog.
Scand J Gastroenterol
13:
759-765,
1978[ISI][Medline].
93.
Marinelli, RA,
Pham L,
Agre P,
and
LaRusso NF.
Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane. Evidence for a secretin-induced vesicular translocation of aquaporin-1.
J Biol Chem
272:
12984-12988,
1997
94.
Marinelli, RA,
Pham LD,
Tietz PS,
and
LaRusso NF.
Expression of aquaporin-4 water channels in rat cholangiocytes.
Hepatology
31:
1313-1317,
2000[ISI][Medline].
95.
Marinelli, RA,
Tietz PS,
Pham LD,
Rueckert L,
Agre P,
and
LaRusso NF.
Secretin induces the apical insertion of aquaporin-1 water channels in rat cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
276:
G280-G286,
1999
96.
Martinez-Anso, E,
Castillo JE,
Diez J,
Medina JF,
and
Prieto J.
Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver.
Hepatology
19:
1400-1406,
1994[ISI][Medline].
97.
Masyuk, AI,
Gong AY,
Kip S,
Burke MJ,
and
LaRusso N.
Perfused rat intrahepatic bile ducts secrete and absorb water, solute, and ions.
Gastroenterology
119:
1672-1680,
2000[ISI][Medline].
98.
McGill, JM,
Basavappa S,
Gettys TW,
and
Fitz JG.
Secretin activates Cl channels in bile duct epithelial cells through a cAMP-dependent mechanism.
Am J Physiol Gastrointest Liver Physiol
266:
G731-G736,
1994
99.
McGill, JM,
Yen MS,
Cummings OW,
Alpini G,
LeSage G,
Pollok KE,
Miller B,
Engle SK,
and
Stansfield AP.
Interleukin-5 inhibition of biliary cell chloride currents and bile flow.
Am J Physiol Gastrointest Liver Physiol
280:
G738-G745,
2001
100.
Mennone, A,
Alvaro D,
Cho W,
and
Boyer JL.
Isolation of small polarized bile duct units.
Proc Natl Acad Sci USA
92:
6527-6531,
1995[Abstract].
101.
Mennone, A,
Biemesderfer D,
Negoianu D,
Yang C-L,
Abbiati T,
Schultheis PJ,
Shull GE,
Aronson PS,
and
Boyer JL.
Role of sodium/hydrogen exchanger isoform NHE3 in fluid secretion and absorption in mouse and rat cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
280:
G247-G254,
2001
102.
Mutt, V,
and
Said SI.
Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination.
Eur J Biochem
42:
581-589,
1974[ISI][Medline].
103.
Nahrwold, DL.
Secretion by the common bile duct in response to secretin.
Surg Forum
22:
386-387,
1971[Medline].
104.
Naruse, S,
Ito O,
Kitagawa M,
Ishiguro H,
Nakajima M,
and
Hayakawa T.
Effects of PACAP/VIP/secretin on pancreatic and gastrointestinal blood flow in conscious dogs.
Ann NY Acad Sci
865:
463-465,
1998
105.
Nathanson, MH,
and
Boyer JL.
Mechanisms and regulation of bile secretion.
Hepatology
14:
551-566,
1991[ISI][Medline].
106.
Nathanson, MH,
Burgstahler AD,
Mennone A,
and
Boyer JL.
Characterization of cytosolic Ca2+ signaling in rat bile duct epithelia.
Am J Physiol Gastrointest Liver Physiol
271:
G86-G96,
1996
107.
Nielsen, S,
Smith BL,
Christensen EI,
and
Agre P.
Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia.
Proc Natl Acad Sci USA
90:
7275-7259,
1993[Abstract].
108.
Nielsen, S,
Smith BL,
Christensen EI,
Knepper MA,
and
Agre P.
CHIP28 water channels are localized in constitutively water-permeable segments of the nephron.
J Cell Biol
120:
371-383,
1993[Abstract].
109.
Numaguchi, K,
Shimokawa H,
Nakaike R,
Egashira K,
and
Takeshita A.
PKC inhibitors prevent endothelial dysfunction after myocardial ischemia-reperfusion in rats.
Am J Physiol Heart Circ Physiol
270:
H1634-H1639,
1996
110.
Nyberg, B,
Einarsson K,
and
Sonnenfeld T.
Evidence that vasoactive intestinal peptide induces ductular secretion of bile in humans.
Gastroenterology
96:
920-924,
1989[ISI][Medline].
111.
Nyberg, B,
Sonnenfeld T,
and
Einarsson K.
Vasoactive intestinal peptide and secretin: effects of combined and separate intravenous infusions on bile secretion in man.
Scand J Gastroenterol
26:
109-118,
1991[ISI][Medline].
112.
Ookhtens, M,
and
Kaplowitz N.
Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine.
Semin Liver Dis
18:
313-329,
1998[ISI][Medline].
113.
Park, CG,
Ganguli SC,
Pinon DI,
Hadac EM,
and
Miller LJ.
Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
J Pharmacol Exp Ther
295:
682-688,
2000
114.
Penn, RB,
Pronin AN,
and
Benovic JL.
Regulation of G protein-coupled receptor kinases.
Trends Cardiovasc Med
10:
81-89,
2000[ISI][Medline].
115.
Rappaport, AM.
The microcirculatory hepatic unit.
Microvasc Res
6:
212-228,
1973[ISI][Medline].
116.
Reilly, FD,
McCuskey PA,
and
McCuskey RS.
Intrahepatic distribution of nerves in the rat.
Anat Rec
191:
55-68,
1978[ISI][Medline].
117.
Rene, E,
Danzinger RG,
Hofmann AF,
and
Nakagaki M.
Pharmacologic effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis.
Gastroenterology
84:
120-129,
1983[ISI][Medline].
118.
Ricci, GL,
and
Fevery J.
Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat.
Gut
30:
1266-1269,
1989[Abstract].
119.
Roberts, S,
Kuntz S,
Gores G,
and
LaRusso N.
Regulation of bicarbonate-dependent ductular secretion assessed by lumenal micropuncture of isolated rodent intrahepatic bile ducts.
Proc Natl Acad Sci USA
90:
9080-9084,
1993[Abstract].
120.
Roberts, SK,
Ludwig J,
and
LaRusso NF.
The pathobiology of biliary epithelia.
Gastroenterology
112:
269-279,
1997[ISI][Medline].
121.
Roberts, SK,
Yano M,
Ueno Y,
Pham L,
Alpini G,
Agre P,
and
LaRusso NF.
Cholangiocytes express the aquaporin CHIP and transport water via a channel-mediated mechanism.
Proc Natl Acad Sci USA
91:
13009-13013,
1994
122.
Rous, P,
and
McMaster P.
Physiological causes for the varied character of stasis bile.
J Exp Med
34:
75,
1921.
123.
Saunders, MD,
Shulman HM,
Murakami CS,
Chauncey TR,
Bensinger WI,
and
McDonald GB.
Bile duct apoptosis and cholestasis resembling acute graft-vs.-host disease after autologous hematopoietic cell transplantation.
Am J Surg Pathol
24:
1004-1008,
2000[ISI][Medline].
124.
Schaffner, F,
and
Popper H.
Electron microscopic studies of normal and proliferated bile ductules.
Am J Pathol
38:
393-410,
1961[ISI].
125.
Shattuck, KE,
Grinnell CD,
and
Rassin DK.
Biliary amino acid and glutathione secretion in response to amino acid infusion in the isolated rat liver.
J Parenter Enteral Nutr
18:
119-127,
1994[Abstract].
126.
Shetzline, MA,
Premont RT,
Walker JK,
Vigna SR,
and
Caron MG.
A role for receptor kinases in the regulation of class II G protein-coupled receptors. Phosphorylation and desensitization of the secretin receptor.
J Biol Chem
273:
6756-6762,
1998
127.
Simonson, MS.
Endothelins: multifunctional renal peptides.
Physiol Rev
73:
375-411,
1993
128.
Smith, ND,
and
Boyer JL.
Permeability characteristics of bile duct in the rat.
Am J Physiol Gastrointest Liver Physiol
242:
G52-G57,
1982
129.
Spirli, C,
Granato A,
Zsembery A,
Anglani F,
Okolicsanyi L,
LaRusso NF,
Crepaldi G,
and
Strazzabosco M.
Functional polarity of Na+/H+ and Cl/HCO
130.
Sreedharan, SP,
Patel DR,
Xia M,
Ichikawa S,
and
Goetzl EJ.
Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways.
Biochem Biophys Res Commun
203:
141-148,
1994[ISI][Medline].
131.
Strasberg, SM,
Petrunka CN,
and
Ilson RG.
The contribution of the extrahepatic bile ducts to bile formation.
Can J Physiol Pharmacol
54:
757-763,
1976[ISI][Medline].
132.
Strazzabosco, M.
New insights into cholangiocyte physiology.
J Hepatol
27:
945-952,
1997[ISI][Medline].
133.
Strazzabosco, M,
Joplin R,
Zsembery A,
Wallace L,
Spirli C,
Fabris L,
Granato A,
Rossanese A,
Poci C,
Neuberger JM,
Okolicsanyi L,
and
Crepaldi G.
Na(+)-dependent and -independent Cl/HCO
134.
Strazzabosco, M,
Mennone A,
and
Boyer JL.
Intracellular pH regulation in isolated rat bile duct epithelial cells.
J Clin Invest
87:
1503-1512,
1991[ISI][Medline].
135.
Strazzabosco, M,
Spirli C,
and
Okolicsanyi L.
Pathophysiology of the intrahepatic biliary epithelium.
J Gastroenterol Hepatol
15:
244-253,
2000[ISI][Medline].
136.
Strazzabosco, M,
Zsembery A,
and
Fabris L.
Electrolyte transport in bile ductular epithelial cells.
J Hepatol
24:
78-87,
1996[ISI][Medline].
137.
Sugiura, H,
and
Nakanuma Y.
Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary glands in normal livers and hepatholithiasis.
Gastroenterologia Japonica
24:
308-314,
1989[Medline].
138.
Svoboda, M,
Tastenoy M,
De Neef P,
Delporte C,
Waelbroeck M,
and
Robberecht P.
Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor.
Peptides
19:
1055-1062,
1998[ISI][Medline].
139.
Takahashi, A,
Watkins SC,
Howard M,
and
Frizzell RA.
CFTR-dependent membrane insertion is linked to stimulation of the CFTR chloride conductance.
Am J Physiol Cell Physiol
271:
C1887-C1894,
1996
140.
Tavoloni, N.
The intrahepatic biliary epithelium: an area of growing interest in hepatology.
Semin Liver Dis
7:
280-292,
1987[ISI][Medline].
141.
Tavoloni, N.
Permeation patterns of polar nonelectrolytes across the guinea pig biliary tree.
Am J Physiol Gastrointest Liver Physiol
247:
G527-G536,
1984
142.
Tavoloni, N,
and
Schaffner F.
The intrahepatic biliary epithelium in the guinea pig: is hepatic artery blood flow essential in maintaining its function and structure?
Hepatology
55:
666-672,
1985.
143.
Tietz, P,
Alpini G,
Pham LD,
and
LaRusso NF.
Somatostatin inhibits secretin-induced ductal choleresis in vivo and exocytosis by cholangiocytes.
Am J Physiol Gastrointest Liver Physiol
269:
G110-G118,
1995
144.
Tietz, P,
Levine S,
Holman R,
Fretham C,
and
LaRusso NF.
Characterization of apical and basolateral plasma membrane domains derived from cultured rat cholangiocytes.
Anal Biochem
254:
192-199,
1997[ISI][Medline].
145.
Tietz, PS,
Holman RT,
Miller LJ,
and
LaRusso NF.
Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains.
Biochemistry
34:
15436-15443,
1995[ISI][Medline].
146.
Trauner, M,
Mennone A,
Gigliozzi A,
Fraioli F,
and
Boyer JL.
Nitric oxide and guanosine 3',5'-cyclic monophosphate stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units.
Hepatology
28:
1621-1628,
1998[ISI][Medline].
147.
Tsuneki, K,
and
Ichihara K.
Electron microscope study of vertebrate liver innervation.
Arch Histol Jpn
44:
1-13,
1981[Medline].
148.
Ulrich, C, II,
Holtmann M,
and
Miller JL.
Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.
Gastroenterology
114:
382-397,
1998[ISI][Medline].
149.
Verkman, AS.
Mechanisms and regulation of water permeability in renal epithelia.
Am J Physiol Cell Physiol
257:
C837-C850,
1989
150.
Villanger, O,
Veel T,
and
Raeder MG.
Secretin causes H+ secretion from intrahepatic bile ductules by vacuolar-type H+-ATPase.
Am J Physiol Gastrointest Liver Physiol
265:
G719-G724,
1993
151.
Vroman, B,
and
LaRusso NF.
Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells.
Lab Invest
74:
303-313,
1996[ISI][Medline].
152.
Walsh, JH.
Gastrointestinal hormones: secretin.
In: Physiology of the Gastrointestinal Tract (2nd ed), edited by Johnson LR.. New York: Raven, 1987, p. 206-224.
153.
Walsh, JH,
and
Mayer EAI
Gastrointestinal hormones.
In: Gastrointestinal Disease (5th ed), edited by Sleisenger MH,
and Fordtran JS.. London, UK: Saunders, 1993, p. 18-44.
154.
Wheeler, HO,
and
Mancusi-Ungaro PL.
Role of bile ducts during secretin choleresis in dogs.
Am J Physiol
210:
1153-1159,
1966[ISI][Medline].
155.
Wheeler, HO,
and
Ramos OL.
Determinants of the flow and composition of bile in the unanesthetized dog during constant infusion of sodium taurocholate.
J Clin Invest
39:
161-170,
1960[ISI].
156.
Wheeler, HO,
Ramos OL,
and
Whitlock RT.
Electrolyte excretion in bile.
Circulation
21:
988-996,
1960[ISI].
157.
Yang, L,
Faris RA,
and
Hixson DC.
Long-term culture and characteristics of normal rat liver bile duct epithelial cells.
Gastroenterology
104:
840-852,
1993[ISI][Medline].
158.
Yasoshima, M,
Kono N,
Sugawara H,
Katayanagi K,
Harada K,
and
Nakanuma Y.
Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study.
Lab Invest
78:
89-100,
1998[ISI][Medline].
159.
Yassin, RR,
Clearfield HR,
and
Little KM.
Gastrin's trophic effect in the colon: identification of a signaling pathway mediated by protein kinase C.
Peptides
14:
1119-1124,
1993[ISI][Medline].
160.
Yassin, RR,
and
Little KM.
Early signaling mechanism in colonic epithelial cell response to gastrin.
Biochem J
311:
945-950,
1995[ISI][Medline].